Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q4 CY2024 results , with sales up 14.6% year on year to ...

Discover the Start-ups Revolutionizing Healthcare in Diagnostics, Gene Editing, and AI-Driven MedicineDublin, Feb. 04, 2025 (GLOBE NEWSWIRE) -- The "Start-up Series - Unicorn Quest: Innovators in ...

Piper Sandler analyst David Westenberg raised the firm’s price target on Quest Diagnostics (DGX) to $180 from $165 and keeps a Neutral rating ...

In a report released on January 31, Elizabeth Anderson CFA from Evercore ISI maintained a Hold rating on Quest Diagnostics (DGX – Research ...

Following the earnings announcement, Quest Diagnostics (NYSE:DGX)' stock price rose by 0.48% in pre-market trading. The stock ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been selected as one of the 2025 World's Most Admired Companies™ by Fortune® magazine, ...

Quest Diagnostics' fourth-quarter net income and revenue rose beyond Wall Street expectations, and the medical firm forecast more growth in 2025 amid rising demand for its health-care tests.

This was the stock's second consecutive day of losses.